Analyst Price Target is $16.67
▲ +1,343.00% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Calidi Biotherapeutics in the last 3 months. The average price target is $16.67, with a high forecast of $20.00 and a low forecast of $10.00. The average price target represents a 1,343.00% upside from the last price of $1.16.
Current Consensus is
Buy
The current consensus among 3 investment analysts is to buy stock in Calidi Biotherapeutics.